Detalhe da pesquisa
1.
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476).
Int J Cancer
; 151(3): 422-434, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35411939
2.
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial.
Lancet
; 392(10162): 2353-2366, 2018 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30355464
3.
Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial.
Lancet Oncol
; 13(5): 549-58, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22452894
4.
Chemoradiotherapy in Muscle-invasive Bladder Cancer: 10-yr Follow-up of the Phase 3 Randomised Controlled BC2001 Trial.
Eur Urol
; 82(3): 273-279, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35577644
5.
Additional Treatments to the Local tumour for metastatic prostate cancer-Assessment of Novel Treatment Algorithms (IP2-ATLANTA): protocol for a multicentre, phase II randomised controlled trial.
BMJ Open
; 11(2): e042953, 2021 02 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33632752
6.
Positive parental attitudes to participating in research involving newborn screened infants with CF.
J Cyst Fibros
; 12(3): 234-40, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23040821
7.
Randomized noninferiority trial of reduced high-dose volume versus standard volume radiation therapy for muscle-invasive bladder cancer: results of the BC2001 trial (CRUK/01/004).
Int J Radiat Oncol Biol Phys
; 87(2): 261-9, 2013 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23958147